Biostage (OTCMKTS:BSTG) is scheduled to be releasing its earnings data before the market opens on Thursday, March 28th.

Shares of BSTG stock opened at $2.46 on Wednesday. Biostage has a one year low of $1.91 and a one year high of $5.85.

COPYRIGHT VIOLATION WARNING: “Biostage (BSTG) Scheduled to Post Quarterly Earnings on Thursday” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at

Biostage Company Profile

Biostage, Inc, a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants. It is developing bioengineered organ implants, which addresses the damage of the esophagus, bronchus, and trachea due to cancer, infection, trauma, or congenital abnormalities.

See Also: How does a 12b-1 fee affect fund performance?

Earnings History for Biostage (OTCMKTS:BSTG)

Receive News & Ratings for Biostage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostage and related companies with's FREE daily email newsletter.